| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.10e-09 | 14 | 173 | 6 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.89e-08 | 21 | 173 | 6 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.04e-08 | 11 | 173 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.51e-07 | 38 | 173 | 6 | GO:0034061 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 SETMAR SGIP1 MCM5 ERVK-7 ERVK-10 RECQL5 ERVK-8 ERVK-11 NIPBL XRCC6 TOP2B | 3.17e-06 | 262 | 173 | 12 | GO:0140097 |
| GeneOntologyMolecularFunction | peptidase activity | ATG4A USP53 ERVK-6 RELN SFRP1 ADAM7 ERVK-7 ADAMTS5 ERVK-10 AMZ2 PRCP UFD1 GZMK ERVK-8 ERVK-18 MMP2 ADAMTS14 AGTPBP1 CAPN15 | 4.21e-06 | 654 | 173 | 19 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.60e-05 | 37 | 173 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.60e-05 | 37 | 173 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.83e-05 | 38 | 173 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.74e-05 | 46 | 173 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 5.49e-05 | 152 | 173 | 8 | GO:0016779 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 6.39e-05 | 79 | 173 | 6 | GO:0004521 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ATG4A ERVK-6 SFRP1 ADAM7 ERVK-7 ADAMTS5 ERVK-10 GZMK ERVK-8 ERVK-18 MMP2 ADAMTS14 CAPN15 | 9.97e-05 | 430 | 173 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 SETMAR SGIP1 MCM5 TUT1 ERVK-7 ERVK-10 YARS1 IARS2 RECQL5 RCL1 ERVK-8 ERVK-11 NIPBL XRCC6 TOP2B | 1.61e-04 | 645 | 173 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 1.71e-04 | 13 | 173 | 3 | GO:0005024 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.85e-04 | 136 | 173 | 7 | GO:0004519 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 GAK SGIP1 IP6K1 TUT1 ERVK-7 ERVK-10 ACVRL1 STK31 TTK MKNK1 TGFBR3 ERVK-8 PRKCD LTBP1 FGR ERVK-11 MAP2K3 EPHA4 PARP15 | 1.87e-04 | 938 | 173 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 6.54e-04 | 20 | 173 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 RELN MYH11 ANK1 MAP4 LAMB1 ERVK-7 ERVK-10 CPOX NEB NUP205 RPL23 DAP3 TUBGCP3 ERVK-8 ERVK-18 LTBP1 PLEC | 7.48e-04 | 891 | 173 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.09e-03 | 6 | 173 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.20e-03 | 136 | 173 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 1.28e-03 | 25 | 173 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.44e-03 | 26 | 173 | 3 | GO:0050431 | |
| GeneOntologyBiologicalProcess | DNA integration | 5.04e-10 | 13 | 172 | 6 | GO:0015074 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 6.05e-06 | 83 | 172 | 7 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA recombination | ERVK-6 MCM5 ERVK-7 ERVK-10 BRCA2 RECQL5 ERVK-8 PRMT1 ZFYVE26 ERVK-11 NIPBL XRCC6 TOP2B | 1.36e-05 | 368 | 172 | 13 | GO:0006310 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | ERVK-6 SETMAR MCM5 ERVK-7 ERVK-10 BRCA2 RECQL5 ERVK-8 ERVK-11 | 1.91e-05 | 178 | 172 | 9 | GO:0006261 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 4.87e-05 | 48 | 172 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | cellular response to X-ray | 8.95e-05 | 11 | 172 | 3 | GO:0071481 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | ERVK-6 SETMAR MCM5 ERVK-7 SMG5 ERVK-10 ACVRL1 NHP2 BRCA2 RECQL5 ERVK-8 PRMT1 PRKCD ZFYVE26 HERC2 SLC30A9 ERVK-11 OGA NIPBL GNL3 XRCC6 TOP2B | 9.89e-05 | 1081 | 172 | 22 | GO:0006259 |
| GeneOntologyBiologicalProcess | response to X-ray | 1.08e-04 | 30 | 172 | 4 | GO:0010165 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 SETMAR MCM5 ERVK-7 ERVK-10 BRCA2 RECQL5 ERVK-8 PRMT1 ZFYVE26 HERC2 SLC30A9 ERVK-11 NIPBL XRCC6 TOP2B | 1.09e-04 | 648 | 172 | 16 | GO:0006281 |
| Domain | RCC1 | 7.05e-07 | 20 | 165 | 5 | PF00415 | |
| Domain | RCC1_1 | 9.19e-07 | 21 | 165 | 5 | PS00625 | |
| Domain | RCC1_2 | 9.19e-07 | 21 | 165 | 5 | PS00626 | |
| Domain | RCC1_3 | 9.19e-07 | 21 | 165 | 5 | PS50012 | |
| Domain | - | 1.18e-06 | 22 | 165 | 5 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 1.18e-06 | 22 | 165 | 5 | IPR000408 | |
| Domain | RCC1/BLIP-II | 1.50e-06 | 23 | 165 | 5 | IPR009091 | |
| Domain | HECT | 8.80e-05 | 27 | 165 | 4 | PF00632 | |
| Domain | HECTc | 8.80e-05 | 27 | 165 | 4 | SM00119 | |
| Domain | HECT_dom | 8.80e-05 | 27 | 165 | 4 | IPR000569 | |
| Domain | HECT | 8.80e-05 | 27 | 165 | 4 | PS50237 | |
| Domain | - | 1.62e-04 | 222 | 165 | 9 | 1.25.10.10 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.49e-05 | 165 | 124 | 9 | MM15026 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO5 SART3 MYH10 ACACA MAP4 NSF DYNC2H1 ACOT13 KIAA0586 SPTLC1 MCM5 NOL10 CPOX HNRNPUL1 NHP2 HNRNPAB YARS1 NUP205 RPL23 DAP3 IARS2 CLPB EIF2S3 RRP12 GLS RCL1 MKI67 PRMT1 PRKCD MYO18B NIPBL GNL3 XRCC6 TOP2B XPOT | 5.74e-15 | 1425 | 175 | 35 | 30948266 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH10 ANK1 ACACA MAP4 NSF SPTLC1 SAE1 MCM5 NOL10 HNRNPUL1 NHP2 TTK HNRNPAB YARS1 NUP205 RPL23 DAP3 CELF1 EIF2S3 RRP12 RCL1 MKI67 PRMT1 PLEC MAP2K3 NIPBL GNL3 XRCC6 TOP2B XPOT | 4.39e-12 | 1318 | 175 | 30 | 30463901 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 MYH10 ACACA MAP4 SAE1 MCM5 NOL10 HNRNPUL1 NHP2 HNRNPAB NUP205 RPL23 RRP12 RECQL5 GLS UFD1 TUBGCP3 RCL1 MKI67 PRMT1 PRKCD WDFY3 PLEC HERC2 MAP2K3 NIPBL GNL3 XRCC6 TOP2B XPOT | 8.41e-12 | 1353 | 175 | 30 | 29467282 |
| Pubmed | SART3 DLG5 GAK NSF DYNC2H1 SPTLC1 LAMB1 HNRNPUL1 TTK ITPR3 DAP3 IARS2 AKAP9 CLPB EIF2S3 RRP12 GLS TUBGCP3 RCL1 TMEM131L AKAP11 DNAJC1 HERC2 SLC30A9 OGA GNL3 VPS13B XRCC6 TOP2B AGTPBP1 HERC5 | 1.71e-11 | 1487 | 175 | 31 | 33957083 | |
| Pubmed | IPO5 SART3 MYH10 ACACA MAP4 MCM5 NOL10 HNRNPUL1 NUP205 ITPR3 IARS2 RRP12 RCL1 MKI67 PLEC HERC2 NIPBL GNL3 XRCC6 HERC5 XPOT | 1.95e-11 | 653 | 175 | 21 | 22586326 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 MYH10 GAK ACACA MAP4 SRGAP2 IDH1 HNRNPUL1 HNRNPAB SCAF4 RPL23 IBTK IARS2 SCML2 EIF2S3 RRP12 MKI67 PRMT1 OGA NIPBL GNL3 XRCC6 TOP2B HERC5 | 6.70e-11 | 934 | 175 | 24 | 33916271 |
| Pubmed | IPO5 RELN SETMAR CEP57L1 LAMB1 BIRC2 SRGAP2 SORBS1 SMG5 HNRNPUL1 NHP2 MSTO1 YARS1 LDB2 DGLUCY FRY NPRL2 PPP2R5E CLPB SGSM2 GLS WDFY3 PLEC HERC2 NIPBL XRCC6 AGTPBP1 XPOT | 6.79e-11 | 1285 | 175 | 28 | 35914814 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IPO5 MYH10 SPTLC1 BIRC2 NOL10 CPOX HNRNPUL1 TTK HNRNPAB YARS1 ITPR3 RPL23 DAP3 IBTK IARS2 AKAP9 CLPB NUP37 RRP12 GLS RCL1 PRKCD AKAP11 DNAJC1 HERC2 HERC1 SLC30A9 GNL3 VPS13B XRCC6 | 9.72e-11 | 1496 | 175 | 30 | 32877691 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | IPO5 MYH10 MYH11 ACACA MAP4 ITPR3 RRP12 ANKRD30A PLEC HERC2 XRCC6 TOP2B | 5.44e-10 | 202 | 175 | 12 | 33005030 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IPO5 SART3 EFL1 ACACA MAP4 SAE1 LAMB1 MCM5 TUT1 IDH1 HNRNPUL1 HNRNPAB YARS1 NUP205 RPL23 PPP2R5E PRCP NUP37 EIF2S3 GLS UFD1 PRMT1 PLEC HERC1 OGA XRCC6 XPOT | 4.95e-09 | 1455 | 175 | 27 | 22863883 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SART3 MYH10 ACACA NSF SPTLC1 SAE1 MCM5 SRGAP2 SORBS1 HNRNPUL1 HNRNPAB YARS1 NUP205 DAP3 IBTK NPRL2 EIF2S3 RRP12 PRMT1 AKAP11 HERC2 HERC1 ATP2A3 UNC79 GNL3 | 7.63e-09 | 1284 | 175 | 25 | 17353931 |
| Pubmed | IPO5 SART3 EFL1 MYH10 ACACA ACSM1 SPTLC1 CPOX HNRNPUL1 TTK MSTO1 NUP205 NPRL2 PPP2R5E SLC12A1 CLPB GLCE RECQL5 TMEM131L PRMT1 LTBP1 BRD1 OGA NIPBL CAPN15 | 1.46e-08 | 1327 | 175 | 25 | 32694731 | |
| Pubmed | IPO5 SART3 MYH10 GAK NSF SPTLC1 LAMB1 MCM5 HNRNPUL1 HNRNPAB NUP205 ITPR3 DAP3 IARS2 CLPB EIF2S3 RRP12 UFD1 MKI67 PRMT1 DNAJC1 SLC30A9 XRCC6 TOP2B HERC5 XPOT | 1.71e-08 | 1440 | 175 | 26 | 30833792 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART3 DLG5 MYH10 MAP4 MCM5 NOL10 HNRNPUL1 HNRNPAB YARS1 NUP205 ITPR3 RPL23 DAP3 IARS2 EIF2S3 RRP12 GLS RCL1 MKI67 PRMT1 C3 PLEC GNL3 XRCC6 | 2.27e-08 | 1257 | 175 | 24 | 36526897 |
| Pubmed | IPO5 SART3 MYH10 ACACA NSF MCM5 HNRNPUL1 HNRNPAB NUP205 RPL23 EIF2S3 TUBGCP3 PLEC GNL3 XRCC6 TOP2B XPOT | 2.85e-08 | 638 | 175 | 17 | 33239621 | |
| Pubmed | IPO5 CFAP47 SART3 MYH10 MAP4 NSF MCM5 CPOX HNRNPUL1 HNRNPAB RPL23 MKI67 PRMT1 PLEC XRCC6 | 3.58e-08 | 494 | 175 | 15 | 26831064 | |
| Pubmed | LAMB1 MCM5 HNRNPUL1 HNRNPAB NUP205 ITPR3 RPL23 BRCA2 RRP12 RECQL5 MKI67 C3 PLEC NIPBL GNL3 XRCC6 TOP2B | 3.90e-08 | 652 | 175 | 17 | 31180492 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | IPO5 USP53 SART3 MYH10 NSF DYNC2H1 MCM5 TUT1 NHP2 NUP205 SCML2 CELF1 CLPB GLDC UFD1 TUBGCP3 SPRYD3 MMP2 PLEC HERC2 OGA | 4.12e-08 | 1005 | 175 | 21 | 19615732 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP4 MED14 NOL10 HNRNPUL1 HNRNPAB NUP205 RPL23 IBTK EIF2S3 RRP12 RCL1 MKI67 HERC2 GNL3 XRCC6 TOP2B AGTPBP1 HERC5 | 6.35e-08 | 759 | 175 | 18 | 35915203 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | IPO5 DLG5 MYH10 MYH11 MAP4 MCM5 NOL10 HNRNPUL1 HNRNPAB ITPR3 RPL23 EIF2S3 RRP12 MKI67 C3 PLEC MAP2K3 GNL3 XRCC6 HERC5 | 7.73e-08 | 949 | 175 | 20 | 36574265 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | IPO5 SART3 MYH10 ACACA MAP4 NSF SAE1 MCM5 SRGAP2 IDH1 HNRNPUL1 HNRNPAB YARS1 SCAF4 RPL23 DAP3 EIF2S3 RRP12 PLEC OGA GNL3 XRCC6 | 8.79e-08 | 1149 | 175 | 22 | 35446349 |
| Pubmed | IPO5 MYH10 ACACA MCM5 YARS1 RPL23 EIF2S3 MKI67 PRMT1 AKAP11 GNL3 XRCC6 | 1.29e-07 | 330 | 175 | 12 | 32529326 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | IPO5 MYH10 MYH11 ACACA DYNC2H1 CP IDH1 HNRNPUL1 RPL23 IARS2 AKAP9 EIF2S3 UFD1 PRMT1 PLEC UNC79 XRCC6 XPOT | 1.57e-07 | 807 | 175 | 18 | 30575818 |
| Pubmed | IPO5 SART3 SPTLC1 ANKRD30B MCM5 TUT1 CPOX HNRNPUL1 TTK HNRNPAB NUP205 RPL23 DAP3 PPP2R5E CLPB GLDC NUP37 RRP12 UFD1 RCL1 PRMT1 GNL3 XRCC6 | 2.84e-07 | 1335 | 175 | 23 | 29229926 | |
| Pubmed | ACACA NSF DYNC2H1 SLC6A17 SPTLC1 MED14 LAMB1 HNRNPAB YARS1 NUP205 CLPB BRCA2 EIF2S3 RCL1 MKI67 OGA XRCC6 | 3.05e-07 | 754 | 175 | 17 | 35906200 | |
| Pubmed | MYH10 SPTLC1 BIRC2 CPOX MSTO1 RNF14 DAP3 IARS2 CLPB NUP37 GLS UFD1 SLC30A9 MAP2K3 | 3.95e-07 | 515 | 175 | 14 | 31617661 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SART3 ACACA MED14 MCM5 HNRNPUL1 NUP205 ITPR3 CLPB NUP37 RRP12 MKI67 HERC2 TOP2B | 4.10e-07 | 440 | 175 | 13 | 34244565 |
| Pubmed | SART3 DLG5 MYH10 MYH11 MAP4 ACOT13 SAE1 NOL10 NHP2 SCAF4 NUP205 IBTK AKAP9 CLPB TUBGCP3 RCL1 MKI67 PRMT1 PLEC HERC2 GNL3 XRCC6 AGTPBP1 | 4.51e-07 | 1371 | 175 | 23 | 36244648 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.99e-07 | 4 | 175 | 3 | 10469592 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SART3 EFL1 ACACA SPTLC1 MED14 SAE1 MCM5 MSTO1 NUP205 RPL23 DAP3 IARS2 EIF2S3 ATP2A3 NIPBL TOP2B | 6.23e-07 | 704 | 175 | 16 | 29955894 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYH10 ACACA MCM5 NOL10 HNRNPUL1 HNRNPAB NUP205 RPL23 EIF2S3 RRP12 GLS UFD1 RCL1 MKI67 PRMT1 PLEC GNL3 XRCC6 TOP2B | 6.76e-07 | 989 | 175 | 19 | 36424410 |
| Pubmed | IPO5 MYH10 MAP4 ACOT13 ADAM7 SAE1 IDH1 HNRNPAB RPL23 IARS2 EIF2S3 RECQL5 GLS UFD1 MKI67 PLEC XRCC6 | 7.28e-07 | 803 | 175 | 17 | 36517590 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | IPO5 SART3 MYH10 ACACA MAP4 MCM5 SRGAP2 HNRNPUL1 NHP2 HNRNPAB YARS1 RPL23 DAP3 EIF2S3 RRP12 UFD1 PRMT1 PLEC NIPBL GNL3 XRCC6 TOP2B XPOT | 7.77e-07 | 1415 | 175 | 23 | 28515276 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | IPO5 SART3 MYH10 NOL10 HNRNPUL1 HNRNPAB YARS1 SCML2 CELF1 RRP12 PRMT1 XRCC6 | 8.45e-07 | 394 | 175 | 12 | 27248496 |
| Pubmed | IPO5 MYH10 GAK NSF SMG5 IDH1 SCAF4 ITPR3 IARS2 BRCA2 NUP37 MKI67 LTBP1 XRCC6 TOP2B | 8.63e-07 | 634 | 175 | 15 | 34591612 | |
| Pubmed | MYH10 MAP4 NSF SPTLC1 BIRC2 MCM5 HNRNPUL1 NHP2 HNRNPAB MSTO1 RPL23 EIF2S3 PRMT1 GNL3 XRCC6 XPOT | 9.15e-07 | 725 | 175 | 16 | 27025967 | |
| Pubmed | SART3 NOL10 NHP2 NUP205 NUP37 RRP12 RCL1 MKI67 BRD1 GNL3 TOP2B | 1.09e-06 | 332 | 175 | 11 | 25693804 | |
| Pubmed | SART3 ITPR3 IBTK CLPB UFD1 PRMT1 LTBP1 PLEC HERC2 HERC1 XRCC6 AGTPBP1 CAPN15 | 1.11e-06 | 481 | 175 | 13 | 28190767 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IPO5 MAP4 NSF MCM5 HNRNPUL1 HNRNPAB SCAF4 NUP205 ITPR3 RPL23 RRP12 MKI67 PRMT1 PLEC HERC2 NIPBL GNL3 XRCC6 TOP2B | 1.13e-06 | 1024 | 175 | 19 | 24711643 |
| Pubmed | IPO5 MYH10 ACACA NSF CPOX HNRNPAB NUP205 RPL23 EIF2S3 RRP12 PRMT1 GNL3 TOP2B | 1.19e-06 | 484 | 175 | 13 | 31995728 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.24e-06 | 5 | 175 | 3 | 12629516 | |
| Pubmed | 1.24e-06 | 5 | 175 | 3 | 15676274 | ||
| Pubmed | IPO5 DLG5 MYH10 ACACA MAP4 NSF MED14 SAE1 LAMB1 MCM5 IDH1 HNRNPUL1 ITPR3 RPL23 NPRL2 AKAP9 EIF2S3 MKI67 MAP2K3 GNL3 XRCC6 | 1.40e-06 | 1247 | 175 | 21 | 27684187 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.41e-06 | 212 | 175 | 9 | 33462405 | |
| Pubmed | MYH10 NSF MCM5 SRGAP2 HNRNPUL1 NHP2 HNRNPAB NUP205 ITPR3 NUP37 EIF2S3 MKI67 PLEC XRCC6 TOP2B | 1.42e-06 | 660 | 175 | 15 | 32780723 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | IPO5 ACACA NSF SPTLC1 SAE1 MCM5 CPOX HNRNPUL1 HNRNPAB NUP205 RPL23 IARS2 CLPB NUP37 EIF2S3 UFD1 PRMT1 OGA GNL3 XRCC6 XPOT | 1.59e-06 | 1257 | 175 | 21 | 37317656 |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 1.71e-06 | 217 | 175 | 9 | 31685992 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.91e-06 | 220 | 175 | 9 | 35785414 | |
| Pubmed | MYH10 THSD7A HNRNPUL1 RYR2 LDB2 TXNIP RNF14 PPP2R5E CLPB PLEC HERC2 HERC1 BRD1 XRCC6 | 2.00e-06 | 591 | 175 | 14 | 15231748 | |
| Pubmed | SART3 DLG5 MAP4 NSF MED14 MCM5 NOL10 SRGAP2 NHP2 SCAF4 SCML2 PPP2R5E CLPB NUP37 EIF2S3 RRP12 RECQL5 RCL1 PRMT1 DNAJC1 HERC2 NIPBL GNL3 | 2.01e-06 | 1497 | 175 | 23 | 31527615 | |
| Pubmed | 2.14e-06 | 223 | 175 | 9 | 20020773 | ||
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 2.23e-06 | 42 | 175 | 5 | 29348145 | |
| Pubmed | SETMAR GAK ACACA NSF DYNC2H1 SPTLC1 TTK IARS2 BRCA2 RRP12 HERC2 MAP2K3 XRCC6 XPOT | 2.67e-06 | 606 | 175 | 14 | 36538041 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | IPO5 NSF MCM5 IDH1 HNRNPUL1 YARS1 NUP205 DAP3 IARS2 CLPB EIF2S3 GLS PRMT1 C3 | 2.72e-06 | 607 | 175 | 14 | 39147351 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 2.85e-06 | 231 | 175 | 9 | 36597993 | |
| Pubmed | IPO5 MYH10 ACACA MAP4 ACOT13 MCM5 NHP2 HNRNPAB YARS1 NUP205 RPL23 EIF2S3 PRMT1 PLEC XRCC6 | 3.28e-06 | 707 | 175 | 15 | 19738201 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | MYH11 NSF MCM5 HNRNPUL1 HNRNPAB YARS1 RPL23 DAP3 CELF1 RRP12 MKI67 PRMT1 GNL3 XRCC6 TOP2B | 3.69e-06 | 714 | 175 | 15 | 28302793 |
| Pubmed | SART3 MYH10 MYH11 ADAM7 ANKRD30B MCM5 CPOX NEB STK31 HNRNPAB RYR2 NUP205 DAP3 GLS ANKRD30A CFAP74 PLEC ATP2A3 NIPBL XRCC6 TOP2B EPHA4 | 3.83e-06 | 1442 | 175 | 22 | 35575683 | |
| Pubmed | IPO5 SART3 EFL1 MAP4 MED14 SAE1 MCM5 YARS1 NUP205 UFD1 MKI67 PRMT1 PLEC MAP2K3 NIPBL GNL3 XRCC6 TOP2B | 4.07e-06 | 1014 | 175 | 18 | 32416067 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 4.25e-06 | 182 | 175 | 8 | 31067453 | |
| Pubmed | 4.29e-06 | 383 | 175 | 11 | 29331416 | ||
| Pubmed | Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice. | 4.32e-06 | 7 | 175 | 3 | 36897941 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | MAP4 MCM5 SORBS1 HNRNPUL1 HNRNPAB YARS1 NUP205 CELF1 MKI67 PRMT1 | 4.93e-06 | 315 | 175 | 10 | 26777405 |
| Pubmed | IPO5 SART3 MYH10 ACACA MAP4 NSF MCM5 SCAF4 CLPB UFD1 PRMT1 GNL3 XRCC6 XPOT | 6.26e-06 | 653 | 175 | 14 | 33742100 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | IPO5 SART3 LAMB1 HNRNPUL1 NHP2 TTK HNRNPAB PPP2R5E NUP37 RRP12 TUBGCP3 MKI67 PRMT1 HERC2 NIPBL GNL3 VPS13B XRCC6 TOP2B | 6.43e-06 | 1155 | 175 | 19 | 20360068 |
| Pubmed | NOL10 NHP2 TTR RPL23 EIF2S3 RRP12 RCL1 MKI67 C3 GNL3 XRCC6 HERC5 | 6.83e-06 | 483 | 175 | 12 | 36912080 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 6.88e-06 | 8 | 175 | 3 | 19033399 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | USP53 DLG5 MYH10 ACACA CP MCM5 SORBS1 TTK MSTO1 NUP205 IBTK IARS2 BRCA2 PLEC HERC2 GNL3 | 7.25e-06 | 853 | 175 | 16 | 28718761 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SART3 MAP4 NOL10 HNRNPUL1 HNRNPAB SCAF4 RPL23 SCML2 BRCA2 EIF2S3 RECQL5 RCL1 MKI67 NIPBL GNL3 XRCC6 TOP2B | 7.26e-06 | 954 | 175 | 17 | 36373674 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | MAP4 NSF DYNC2H1 TUT1 IDH1 C2CD2 NUP205 DGLUCY IARS2 EIF2S3 GLCE UFD1 LTBP1 WDFY3 HERC1 ATP2A3 GNPAT XPOT | 7.54e-06 | 1061 | 175 | 18 | 33845483 |
| Pubmed | 7.61e-06 | 197 | 175 | 8 | 31620119 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 8.41e-06 | 94 | 175 | 6 | 21542922 | |
| Pubmed | 8.45e-06 | 335 | 175 | 10 | 15741177 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 8.93e-06 | 95 | 175 | 6 | 29643511 | |
| Pubmed | IPO5 SORBS1 NEB PPP2R5E AKAP9 TUBGCP3 MMP2 PLEC MYO18B GNL3 XRCC6 AGTPBP1 | 9.09e-06 | 497 | 175 | 12 | 23414517 | |
| Pubmed | IPO5 MYH10 GAK ACACA SPTLC1 LAMB1 HNRNPUL1 TTK HNRNPAB YARS1 RPL23 PRCP EIF2S3 GLS MKI67 C3 NIPBL GNL3 XRCC6 XPOT | 9.36e-06 | 1297 | 175 | 20 | 33545068 | |
| Pubmed | MYH10 MYH11 MAP4 HNRNPUL1 HNRNPAB SCAF4 CELF1 NIPBL XRCC6 TOP2B | 9.61e-06 | 340 | 175 | 10 | 24332808 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ACACA MAP4 MED14 HNRNPUL1 SCAF4 SCML2 RRP12 MKI67 PRKCD PLEC OGA NIPBL XRCC6 TOP2B AGTPBP1 | 9.66e-06 | 774 | 175 | 15 | 15302935 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DLG5 RELN MYH10 MED14 HNRNPUL1 HNRNPAB SCAF4 NUP205 RPL23 DAP3 RRP12 TUBGCP3 RCL1 PRMT1 PLEC NIPBL XRCC6 TOP2B | 9.83e-06 | 1082 | 175 | 18 | 38697112 |
| Pubmed | 1.13e-05 | 208 | 175 | 8 | 11790298 | ||
| Pubmed | 1.13e-05 | 274 | 175 | 9 | 34244482 | ||
| Pubmed | SETMAR MAP4 MED14 MCM5 HNRNPUL1 NEB EIF2S3 HERC2 ATP2A3 XRCC6 AGTPBP1 CAPN15 | 1.25e-05 | 513 | 175 | 12 | 25798074 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | ACACA NEB MKNK1 RPL23 AKAP9 PRMT1 PRKCD AKAP11 WDFY3 GNL3 VPS13B | 1.33e-05 | 432 | 175 | 11 | 23455922 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | IPO5 NHP2 DAP3 SCML2 RECQL5 RCL1 MKI67 HERC2 BRD1 NIPBL GNL3 XRCC6 TOP2B | 1.39e-05 | 608 | 175 | 13 | 36089195 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | IPO5 GAK ACACA NSF SPTLC1 LAMB1 CP MCM5 ADAMTS5 IDH1 CPOX RPL23 DGLUCY IARS2 AKAP9 GLCE GLS LTBP1 MMP2 PLEC ADAMTS14 | 1.43e-05 | 1451 | 175 | 21 | 30550785 |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.56e-05 | 157 | 175 | 7 | 30686591 | |
| Pubmed | 1.57e-05 | 360 | 175 | 10 | 33111431 | ||
| Pubmed | MYH10 MAP4 MCM5 HNRNPUL1 HNRNPAB YARS1 AMZ2 RPL23 DAP3 IARS2 EIF2S3 MMP2 PLEC GNL3 XRCC6 | 1.62e-05 | 809 | 175 | 15 | 32129710 | |
| Pubmed | IPO5 SART3 MAP4 IDH1 NHP2 HNRNPAB YARS1 NUP205 ITPR3 EIF2S3 C3 PLEC GNL3 XRCC6 | 1.62e-05 | 711 | 175 | 14 | 33022573 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 1.69e-05 | 220 | 175 | 8 | 34091597 | |
| Pubmed | 1.70e-05 | 159 | 175 | 7 | 22751105 | ||
| Pubmed | 1.97e-05 | 65 | 175 | 5 | 28276505 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | MED14 NOL10 TUT1 CPOX NHP2 IARS2 RRP12 RCL1 MAP2K3 GNL3 XRCC6 | 2.10e-05 | 454 | 175 | 11 | 33226137 |
| Pubmed | 2.29e-05 | 67 | 175 | 5 | 29254152 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 38771357 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 25313763 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21717526 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 3678603 | ||
| Pubmed | The classical pathway triggers pathogenic complement activation in membranous nephropathy. | 2.52e-05 | 2 | 175 | 2 | 36709213 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 18586264 | ||
| Interaction | LRRC31 interactions | IPO5 MYH10 MYH11 ACACA MAP4 ITPR3 RRP12 ANKRD30A PLEC HERC2 XRCC6 TOP2B | 1.57e-07 | 205 | 168 | 12 | int:LRRC31 |
| Interaction | BIRC3 interactions | IPO5 SART3 MAP4 NSF DYNC2H1 ACOT13 KIAA0586 SPTLC1 BIRC2 MCM5 NOL10 CPOX HNRNPUL1 NHP2 HNRNPAB YARS1 NUP205 RPL23 DAP3 IARS2 CLPB EIF2S3 RRP12 GLS RCL1 MKI67 PRMT1 PRKCD GNL3 XRCC6 TOP2B | 1.75e-07 | 1334 | 168 | 31 | int:BIRC3 |
| Interaction | NAA40 interactions | SART3 MYH10 GAK ACACA MAP4 SRGAP2 IDH1 HNRNPUL1 HNRNPAB SCAF4 RPL23 IBTK IARS2 SCML2 EIF2S3 RRP12 MKI67 PRMT1 OGA NIPBL GNL3 XRCC6 TOP2B HERC5 XPOT | 5.78e-07 | 978 | 168 | 25 | int:NAA40 |
| Interaction | SIRT7 interactions | IPO5 SART3 MYH10 ACACA MAP4 MCM5 NOL10 HNRNPUL1 NUP205 ITPR3 IARS2 RRP12 RCL1 MKI67 PLEC HERC2 NIPBL GNL3 XRCC6 HERC5 XPOT | 1.07e-06 | 744 | 168 | 21 | int:SIRT7 |
| Interaction | NR2C2 interactions | MYH10 ANK1 ACACA MAP4 NSF SPTLC1 SAE1 MCM5 NOL10 HNRNPUL1 NHP2 TTK HNRNPAB YARS1 NUP205 RPL23 DAP3 CELF1 EIF2S3 RRP12 RCL1 MKI67 PRMT1 PLEC MAP2K3 NIPBL GNL3 XRCC6 TOP2B XPOT | 1.63e-06 | 1403 | 168 | 30 | int:NR2C2 |
| Interaction | CIT interactions | IPO5 MYH10 MYH11 NSF DYNC2H1 MCM5 NOL10 ADGRV1 HNRNPUL1 ACVRL1 NHP2 HNRNPAB NUP205 ITPR3 RPL23 AKAP9 CLPB NUP37 MROH2B RRP12 RCL1 MKI67 PLEC HERC1 NIPBL GNL3 XRCC6 TOP2B XPOT NLRP5 | 3.18e-06 | 1450 | 168 | 30 | int:CIT |
| Interaction | ANAPC2 interactions | DLG5 GAK KIAA0586 TTK YARS1 BRCA2 EIF2S3 UFD1 TUBGCP3 HERC5 EPHA4 | 4.46e-06 | 234 | 168 | 11 | int:ANAPC2 |
| Interaction | BRCA1 interactions | IPO5 CFAP47 SART3 MYH10 ACACA MAP4 NSF CEP57L1 MCM5 CPOX HNRNPUL1 HNRNPAB RPL23 CABYR BRCA2 NUP37 RECQL5 RCL1 MKI67 PRMT1 PLEC HERC2 HERC1 BRD1 NIPBL XRCC6 TOP2B | 4.80e-06 | 1249 | 168 | 27 | int:BRCA1 |
| Interaction | HECTD1 interactions | MYH10 ACACA MAP4 MED14 NOL10 SRGAP2 HNRNPUL1 HNRNPAB NUP205 RPL23 IBTK EIF2S3 RRP12 TUBGCP3 RCL1 SPRYD3 MKI67 HERC2 GNL3 XRCC6 TOP2B AGTPBP1 HERC5 | 7.57e-06 | 984 | 168 | 23 | int:HECTD1 |
| Interaction | COX15 interactions | MYH11 HNRNPUL1 NHP2 HNRNPAB DAP3 IARS2 CLPB RRP12 GLS SLC30A9 ATP2A3 XRCC6 TOP2B | 8.40e-06 | 352 | 168 | 13 | int:COX15 |
| Interaction | EED interactions | IPO5 MYH10 GAK MYH11 ACACA NSF MED14 LAMB1 MCM5 NOL10 HNRNPUL1 NHP2 HNRNPAB SCAF4 NUP205 RPL23 NPRL2 GLDC EIF2S3 RRP12 TUBGCP3 RCL1 PLEC HERC2 MAP2K3 NIPBL GNL3 XRCC6 XPOT | 8.58e-06 | 1445 | 168 | 29 | int:EED |
| Interaction | H2BC4 interactions | MYH10 MYH11 MAP4 SAE1 MCM5 NEB RRP12 MAP2K3 GNL3 XRCC6 TOP2B | 1.17e-05 | 259 | 168 | 11 | int:H2BC4 |
| Interaction | RAD50 interactions | IPO5 USP53 MYH10 MCM5 MKNK1 BRCA2 GLDC RECQL5 PRMT1 BRD1 OGA XRCC6 TOP2B | 1.47e-05 | 371 | 168 | 13 | int:RAD50 |
| Interaction | AURKB interactions | SART3 DLG5 MYH10 MYH11 ADGRV1 HNRNPUL1 ACVRL1 TTK NUP205 CLPB BRCA2 RRP12 TUBGCP3 MKI67 PLEC HERC2 BRD1 XRCC6 NLRP5 | 2.04e-05 | 761 | 168 | 19 | int:AURKB |
| Interaction | UBC interactions | SART3 MYH10 NSF ITPR3 IBTK CLPB UFD1 PRMT1 LTBP1 PLEC HERC2 HERC1 XRCC6 CAPN15 | 2.33e-05 | 446 | 168 | 14 | int:UBC |
| Interaction | FBXL13 interactions | 3.17e-05 | 44 | 168 | 5 | int:FBXL13 | |
| Interaction | STIP1 interactions | IPO5 SART3 MYH10 ACACA NSF MCM5 HNRNPUL1 NEB HNRNPAB NUP205 TXNIP RPL23 NPRL2 EIF2S3 UFD1 TUBGCP3 PLEC GNL3 XRCC6 TOP2B XPOT NLRP5 | 3.36e-05 | 1006 | 168 | 22 | int:STIP1 |
| Interaction | TRIM28 interactions | IPO5 SART3 EFL1 ZNF562 ACACA SPTLC1 MED14 SAE1 MCM5 HNRNPAB MSTO1 NUP205 TXNIP RPL23 DAP3 IARS2 ANKRA2 BRCA2 EIF2S3 RECQL5 RCL1 MKI67 PRMT1 OGA ATP2A3 NIPBL XRCC6 TOP2B | 3.40e-05 | 1474 | 168 | 28 | int:TRIM28 |
| Interaction | ATG16L1 interactions | IPO5 DLG5 ACACA MAP4 KIAA0586 MCM5 SRGAP2 CCDC168 HNRNPUL1 NHP2 TTK HNRNPAB RYR2 ITPR3 RPL23 RRP12 TUBGCP3 C3 WDFY3 PLEC HERC1 XRCC6 TOP2B AGTPBP1 | 3.55e-05 | 1161 | 168 | 24 | int:ATG16L1 |
| Interaction | VCP interactions | IPO5 ACACA NSF CP IP6K1 IDH1 NEB TTK TTR YARS1 NUP205 ITPR3 RPL23 DAP3 GLDC EIF2S3 RRP12 UFD1 GZMK SPRYD3 MKI67 PRMT1 PRKCD C3 PLEC XRCC6 HERC5 | 5.63e-05 | 1435 | 168 | 27 | int:VCP |
| Interaction | ILF3 interactions | MYH10 MAP4 BIRC2 MCM5 CPOX HNRNPUL1 HNRNPAB RPL23 DAP3 IARS2 CELF1 GLDC EIF2S3 RRP12 PRMT1 DNAJC1 MAP2K3 GNL3 XRCC6 HERC5 | 5.94e-05 | 896 | 168 | 20 | int:ILF3 |
| Interaction | SCARNA22 interactions | 5.99e-05 | 118 | 168 | 7 | int:SCARNA22 | |
| Interaction | FBL interactions | IPO5 USP53 EFL1 MCM5 NOL10 NHP2 NUP205 RPL23 RRP12 RCL1 MKI67 PRMT1 BRD1 GNL3 XRCC6 TOP2B | 9.20e-05 | 639 | 168 | 16 | int:FBL |
| Interaction | WDR76 interactions | MYH10 LAMB1 MCM5 HNRNPUL1 HNRNPAB YARS1 CELF1 RRP12 MKI67 PRMT1 PLEC XRCC6 | 9.23e-05 | 383 | 168 | 12 | int:WDR76 |
| Interaction | IMMP2L interactions | SPTLC1 CPOX MSTO1 RNF14 DAP3 IARS2 CLPB NUP37 GLS UFD1 SLC30A9 MAP2K3 | 9.46e-05 | 384 | 168 | 12 | int:IMMP2L |
| Interaction | IFI16 interactions | SART3 NOL10 HNRNPUL1 NHP2 HNRNPAB NUP205 NUP37 EIF2S3 RRP12 RCL1 MKI67 PRMT1 BRD1 GNL3 XRCC6 TOP2B HERC5 | 1.02e-04 | 714 | 168 | 17 | int:IFI16 |
| Interaction | AGR2 interactions | IPO5 MYH10 MYH11 ACACA DYNC2H1 CP IDH1 HNRNPUL1 RPL23 IARS2 AKAP9 EIF2S3 UFD1 PRMT1 C3 TSTD2 PLEC UNC79 XRCC6 XPOT | 1.05e-04 | 934 | 168 | 20 | int:AGR2 |
| Interaction | NDN interactions | IPO5 MYH10 ACACA LAMB1 MCM5 YARS1 RPL23 EIF2S3 MKI67 PRMT1 AKAP11 GNL3 XRCC6 | 1.14e-04 | 453 | 168 | 13 | int:NDN |
| Interaction | HSP90AA1 interactions | CP MCM5 ACVRL1 TTK TTR HNRNPAB TXNIP DAP3 NPRL2 IARS2 BRCA2 GLDC PRMT1 PRKCD C3 MMP2 FGR HERC6 OGA SDR16C5 MAP2K3 NIPBL XRCC6 EPHA4 | 1.32e-04 | 1263 | 168 | 24 | int:HSP90AA1 |
| Interaction | DUSP26 interactions | 1.32e-04 | 59 | 168 | 5 | int:DUSP26 | |
| Interaction | RNF126 interactions | 1.60e-04 | 138 | 168 | 7 | int:RNF126 | |
| Interaction | OBSL1 interactions | LAMB1 MCM5 NOL10 HNRNPUL1 HNRNPAB SCAF4 NUP205 ITPR3 ANKRA2 RRP12 MKI67 PRMT1 PLEC HERC2 NIPBL GNL3 XRCC6 TOP2B AGTPBP1 | 1.94e-04 | 902 | 168 | 19 | int:OBSL1 |
| Interaction | FBXW7 interactions | SART3 MYH10 GAK MAP4 MED14 SAE1 HNRNPUL1 TXNIP DAP3 IARS2 EIF2S3 RRP12 UFD1 SPRYD3 PRMT1 PRKCD C3 PLEC HERC2 GNL3 TOP2B HERC5 XPOT | 1.94e-04 | 1215 | 168 | 23 | int:FBXW7 |
| Interaction | NEFM interactions | 1.98e-04 | 190 | 168 | 8 | int:NEFM | |
| Interaction | USP50 interactions | 1.99e-04 | 35 | 168 | 4 | int:USP50 | |
| Interaction | CHMP4C interactions | MYH10 MYH11 NHP2 HNRNPAB YARS1 NUP205 ITPR3 RPL23 DAP3 IARS2 RRP12 MKI67 LTBP1 GNL3 XRCC6 TOP2B | 2.10e-04 | 687 | 168 | 16 | int:CHMP4C |
| Interaction | RICTOR interactions | SART3 MYH10 MAP4 NSF MCM5 IDH1 NUP205 RPL23 NPRL2 IARS2 RRP12 PLEC BRD1 OGA XRCC6 AGTPBP1 XPOT | 2.10e-04 | 759 | 168 | 17 | int:RICTOR |
| Interaction | NUP214 interactions | 2.37e-04 | 195 | 168 | 8 | int:NUP214 | |
| Interaction | BAP1 interactions | IPO5 SART3 MYH10 ACACA MAP4 NSF SAE1 MCM5 SRGAP2 IDH1 HNRNPUL1 HNRNPAB YARS1 SCAF4 ITPR3 RPL23 DAP3 BRCA2 EIF2S3 RRP12 PLEC OGA GNL3 XRCC6 | 2.38e-04 | 1314 | 168 | 24 | int:BAP1 |
| Interaction | DNAJC7 interactions | DYNC2H1 MKNK1 ITPR3 TXNIP IARS2 BRCA2 EIF2S3 TUBGCP3 PRMT1 HERC2 VPS13B HERC5 | 2.43e-04 | 425 | 168 | 12 | int:DNAJC7 |
| Interaction | PARP1 interactions | IPO5 MYH10 GAK MED14 MCM5 NOL10 HNRNPUL1 HNRNPAB MSTO1 TXNIP RPL23 CLPB BRCA2 GLDC EIF2S3 RRP12 RECQL5 CHFR MKI67 PRMT1 NIPBL GNL3 XRCC6 TOP2B | 2.44e-04 | 1316 | 168 | 24 | int:PARP1 |
| Interaction | EP300 interactions | IPO5 SART3 MYH10 SFRP1 ANK1 ACACA MAP4 NSF MCM5 HNRNPUL1 MSTO1 LDB2 SCAF4 NPRL2 CLPB BRCA2 UFD1 PRMT1 PRKCD C3 HERC1 GNL3 XRCC6 TOP2B XPOT | 2.49e-04 | 1401 | 168 | 25 | int:EP300 |
| Interaction | SIRT6 interactions | SART3 ACACA MED14 MCM5 HNRNPUL1 NUP205 ITPR3 CLPB NUP37 RRP12 MKI67 HERC2 MAP2K3 XRCC6 TOP2B | 2.55e-04 | 628 | 168 | 15 | int:SIRT6 |
| Interaction | FN1 interactions | IPO5 MYH10 ACACA MAP4 ACOT13 MCM5 NHP2 HNRNPAB YARS1 NUP205 RPL23 EIF2S3 PRMT1 C3 LTBP1 MMP2 PLEC XRCC6 | 2.63e-04 | 848 | 168 | 18 | int:FN1 |
| Interaction | ENO1 interactions | IPO5 MYH10 MYH11 ACACA MCM5 NEB YARS1 NUP205 TDRD7 RPL23 CABYR PPP2R5E TOMM40L PRMT1 XRCC6 AGTPBP1 | 2.64e-04 | 701 | 168 | 16 | int:ENO1 |
| Interaction | BTRC interactions | DLG5 ACACA CP NOL10 SMG5 HNRNPUL1 HNRNPAB RPL23 DAP3 EIF2S3 UFD1 TUBGCP3 MKI67 IL17RD XRCC6 TOP2B HERC5 | 2.68e-04 | 775 | 168 | 17 | int:BTRC |
| Interaction | RECQL4 interactions | IPO5 SART3 SPTLC1 ANKRD30B MCM5 TUT1 CPOX HNRNPUL1 TTK HNRNPAB NUP205 RPL23 DAP3 PPP2R5E CLPB GLDC NUP37 RRP12 RECQL5 UFD1 RCL1 PRMT1 PLEC GNL3 XRCC6 | 2.80e-04 | 1412 | 168 | 25 | int:RECQL4 |
| Interaction | PCM1 interactions | IPO5 DLG5 KIAA0586 CEP57L1 SRGAP2 SMG5 HNRNPUL1 TTK IBTK AKAP9 HERC2 BRD1 | 2.93e-04 | 434 | 168 | 12 | int:PCM1 |
| Interaction | HERC2 interactions | MYH10 GAK MAP4 MED14 SRGAP2 SORBS1 TXNIP NPRL2 AKAP9 PLEC HERC2 HERC1 SLC30A9 | 3.15e-04 | 503 | 168 | 13 | int:HERC2 |
| Coexpression | LI_INDUCED_T_TO_NATURAL_KILLER_DN | 2.04e-08 | 137 | 168 | 10 | M2088 | |
| Coexpression | LI_INDUCED_T_TO_NATURAL_KILLER_DN | 2.18e-08 | 138 | 168 | 10 | MM882 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | SFRP1 MAP4 SRGAP2 IDH1 ITPR3 TXNIP NPRL2 GLDC UFD1 MKI67 PRKCD PLEC MAP2K3 | 2.93e-08 | 276 | 168 | 13 | M3063 |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 7.06e-07 | 200 | 168 | 10 | M4538 | |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | IPO5 GAK SAE1 MCM5 HNRNPUL1 MKNK1 DAP3 FRY NPRL2 SCML2 AKAP9 EIF2S3 RECQL5 RCL1 HERC1 OGA XRCC6 GNPAT | 2.69e-06 | 775 | 168 | 18 | M17753 |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 5.84e-06 | 199 | 168 | 9 | M3257 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | IPO5 SART3 MCM5 NHP2 TTK HNRNPAB NUP205 RPL23 IARS2 PPP2R5E BRCA2 TUBGCP3 MKI67 TMEM131L PRMT1 XRCC6 GNPAT | 8.59e-06 | 761 | 168 | 17 | M11961 |
| Coexpression | GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP | 2.21e-05 | 180 | 168 | 8 | M357 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 4.31e-05 | 256 | 168 | 9 | M10952 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN | 4.52e-05 | 199 | 168 | 8 | M5585 | |
| Coexpression | GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN | 4.52e-05 | 199 | 168 | 8 | M5726 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 4.58e-05 | 258 | 168 | 9 | M2446 | |
| Coexpression | EIF4E_DN | 4.59e-05 | 100 | 168 | 6 | M2790 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 4.68e-05 | 200 | 168 | 8 | M7525 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN | 4.68e-05 | 200 | 168 | 8 | M8869 | |
| Coexpression | RAMASWAMY_METASTASIS_UP | 6.64e-05 | 66 | 168 | 5 | M6698 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 6.68e-05 | 271 | 168 | 9 | MM1075 | |
| Coexpression | GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN | 6.85e-05 | 156 | 168 | 7 | M8920 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | RELN MYH11 SFRP1 SORBS1 ACVRL1 TXNIP TGFBR3 GZMK C3 FXYD1 ATP2A3 EPHA4 | 7.34e-05 | 485 | 168 | 12 | M8513 |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 7.73e-05 | 159 | 168 | 7 | M6086 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | ATG4A SLC9A9 PRAMEF19 TUT1 PRAMEF18 ZNF260 DGLUCY KCND2 TOMM40L PRCP RECQL5 ZFYVE26 | 9.24e-05 | 497 | 168 | 12 | MM863 |
| Coexpression | BENPORATH_OCT4_TARGETS | 1.12e-04 | 290 | 168 | 9 | M17183 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | CEP57L1 SAE1 MCM5 ADAMTS5 TTK SCML2 BRCA2 MKI67 FHDC1 IL17RD HERC5 NLRP5 RASD2 | 1.14e-04 | 588 | 168 | 13 | M38992 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SRGAP2 TTK C2CD2 TDRD7 TGFBR3 IBTK PPP2R5E AKAP9 BRCA2 TUBGCP3 TMEM131L AKAP11 WDFY3 NIPBL VPS13B EPHA4 | 1.32e-04 | 856 | 168 | 16 | M4500 |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.36e-04 | 233 | 168 | 8 | M13273 | |
| Coexpression | LIAO_HAVE_SOX4_BINDING_SITES | 1.37e-04 | 41 | 168 | 4 | M15025 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.44e-04 | 300 | 168 | 9 | M8702 | |
| Coexpression | MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER | 1.51e-04 | 42 | 168 | 4 | M8760 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.53e-04 | 237 | 168 | 8 | M15606 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.66e-04 | 240 | 168 | 8 | MM976 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | 1.72e-04 | 307 | 168 | 9 | M19745 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 1.80e-04 | 309 | 168 | 9 | MM1244 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 1.85e-04 | 183 | 168 | 7 | M2993 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN | 1.98e-04 | 185 | 168 | 7 | M8824 | |
| Coexpression | LIAO_METASTASIS | DLG5 MAP4 LAMB1 SMG5 ADAMTS5 YARS1 MKNK1 ITPR3 CABYR RRP12 GLS CHFR | 2.00e-04 | 540 | 168 | 12 | M13809 |
| Coexpression | PGF_UP.V1_UP | 2.33e-04 | 190 | 168 | 7 | M2674 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | IPO5 SETMAR SGIP1 ZNF562 LAMB1 IDH1 CPOX TTK HNRNPAB YARS1 ZNF260 NUP205 SCML2 BRCA2 NUP37 GLS RCL1 MKI67 PRMT1 XRCC6 XPOT | 2.74e-04 | 1407 | 168 | 21 | M14427 |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | 2.82e-04 | 139 | 168 | 6 | M6451 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | IPO5 DLG5 SFRP1 MAP4 BIRC2 CPOX SCML2 PPP2R5E AKAP11 TOP2B GNPAT | 2.89e-04 | 481 | 168 | 11 | M3898 |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 2.90e-04 | 197 | 168 | 7 | M7458 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN | 3.09e-04 | 199 | 168 | 7 | M8314 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP | 3.09e-04 | 199 | 168 | 7 | M8277 | |
| Coexpression | CAMP_UP.V1_DN | 3.09e-04 | 199 | 168 | 7 | M2719 | |
| Coexpression | GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP | 3.09e-04 | 199 | 168 | 7 | M7156 | |
| Coexpression | GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP | 3.09e-04 | 199 | 168 | 7 | M9027 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 3.18e-04 | 408 | 168 | 10 | M11891 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP | 3.18e-04 | 200 | 168 | 7 | M9314 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 3.18e-04 | 200 | 168 | 7 | M8306 | |
| Coexpression | GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN | 3.18e-04 | 200 | 168 | 7 | M8325 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN | 3.18e-04 | 200 | 168 | 7 | M8204 | |
| Coexpression | GSE17721_CTRL_VS_CPG_8H_BMDC_UP | 3.18e-04 | 200 | 168 | 7 | M3767 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 3.18e-04 | 200 | 168 | 7 | M9922 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP | 3.18e-04 | 200 | 168 | 7 | M7192 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN | 3.18e-04 | 200 | 168 | 7 | M3880 | |
| Coexpression | GSE557_CIITA_KO_VS_I_AB_KO_DC_DN | 3.18e-04 | 200 | 168 | 7 | M6014 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN | 3.18e-04 | 200 | 168 | 7 | M6261 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP | 3.18e-04 | 200 | 168 | 7 | M4021 | |
| Coexpression | GSE360_CTRL_VS_T_GONDII_MAC_UP | 3.18e-04 | 200 | 168 | 7 | M5162 | |
| Coexpression | WONG_EMBRYONIC_STEM_CELL_CORE | 3.27e-04 | 335 | 168 | 9 | M7079 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 3.38e-04 | 202 | 168 | 7 | M11840 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 3.50e-04 | 268 | 168 | 8 | M45796 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 3.63e-04 | 415 | 168 | 10 | MM1028 | |
| Coexpression | XU_CREBBP_TARGETS_UP | 3.64e-04 | 22 | 168 | 3 | M17669 | |
| Coexpression | XU_CREBBP_TARGETS_UP | 4.17e-04 | 23 | 168 | 3 | MM641 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | KIAA0586 SAE1 NHP2 STK31 TTK NUP205 TDRD7 IARS2 SCML2 BRCA2 GLDC NUP37 RRP12 RCL1 CHFR AKAP11 HERC1 IL17RD GNL3 XRCC6 XPOT | 1.10e-06 | 810 | 163 | 21 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | MYH11 SFRP1 ACACA LAMB1 CP ADAMTS5 NHP2 STK31 ZNF260 TXNIP RNF14 ADORA1 SCML2 PPP2R5E CLPB PRMT1 PLEC FXYD1 NIPBL | 1.79e-05 | 819 | 163 | 19 | gudmap_developingGonad_P2_testes_1000 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K2 | MYH11 CP SORBS1 ADAMTS5 ACVRL1 TXNIP ADORA1 TGFBR3 MMP2 PLEC FXYD1 | 5.51e-05 | 333 | 163 | 11 | gudmap_RNAseq_e15.5_Podocytes_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.70e-05 | 127 | 163 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | USP53 MAP4 NEB STK31 RYR2 TXNIP ADORA1 SCML2 PPP2R5E KCND2 DNAJC1 WDFY3 PLEC HERC1 XPOT NLRP5 RASD2 | 1.05e-04 | 778 | 163 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.05e-04 | 140 | 163 | 7 | ratio_SC_vs_ECTO_1000_K2 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.10e-04 | 141 | 163 | 7 | ratio_SC_vs_MESO_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.21e-04 | 192 | 163 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | MED14 ZNF260 IBTK AKAP9 CELF1 HERC2 OGA VPS13B TOP2B AGTPBP1 EPHA4 | 1.37e-04 | 369 | 163 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.78e-04 | 203 | 163 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.07e-04 | 110 | 163 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | MYH10 GAK DYNC2H1 KIAA0586 CEP57L1 MED14 HNRNPUL1 CLPB GLDC MKI67 CFAP74 WDFY3 BRD1 OGA | 2.08e-04 | 595 | 163 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ATG4A ANK1 CPOX SCAF4 RCL1 MKI67 TMEM131L FHDC1 HERC1 MYO18B MAP2K3 | 1.38e-10 | 185 | 169 | 11 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-08 | 190 | 169 | 9 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-08 | 190 | 169 | 9 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-08 | 190 | 169 | 9 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.44e-08 | 196 | 169 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-08 | 197 | 169 | 9 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-08 | 200 | 169 | 9 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-08 | 200 | 169 | 9 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-07 | 172 | 169 | 8 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.55e-07 | 189 | 169 | 8 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-07 | 191 | 169 | 8 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-07 | 192 | 169 | 8 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-07 | 193 | 169 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_basal|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 7.98e-07 | 194 | 169 | 8 | b887b2ff19b76bd93c67f9a24762efae816efd45 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 7.98e-07 | 194 | 169 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-07 | 194 | 169 | 8 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-07 | 194 | 169 | 8 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 8.62e-07 | 196 | 169 | 8 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 8.95e-07 | 197 | 169 | 8 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.95e-07 | 197 | 169 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 197 | 169 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.30e-07 | 198 | 169 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.30e-07 | 198 | 169 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.66e-07 | 199 | 169 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.66e-07 | 199 | 169 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-06 | 200 | 169 | 8 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.00e-06 | 200 | 169 | 8 | bc7aba2885ca1093fcd884807b497700dae4835e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-06 | 200 | 169 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.00e-06 | 200 | 169 | 8 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-06 | 200 | 169 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-06 | 200 | 169 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-06 | 200 | 169 | 8 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-06 | 200 | 169 | 8 | cbf6a6c3db88bac37bd084a3a914b12b3af524eb | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-06 | 200 | 169 | 8 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.68e-06 | 160 | 169 | 7 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.62e-06 | 179 | 169 | 7 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-06 | 180 | 169 | 7 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.04e-06 | 181 | 169 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.50e-06 | 183 | 169 | 7 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 7.22e-06 | 186 | 169 | 7 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-06 | 187 | 169 | 7 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-06 | 187 | 169 | 7 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 7.48e-06 | 187 | 169 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-06 | 187 | 169 | 7 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-06 | 187 | 169 | 7 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-06 | 187 | 169 | 7 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 7.48e-06 | 187 | 169 | 7 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.75e-06 | 188 | 169 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.75e-06 | 188 | 169 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.02e-06 | 189 | 169 | 7 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.02e-06 | 189 | 169 | 7 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-06 | 189 | 169 | 7 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | 0bb06df3d5a50416854370f234718c6cec3d773b | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | 008290bb5c79446681dd6bf354336c57ad0d6f13 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 8.30e-06 | 190 | 169 | 7 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.30e-06 | 190 | 169 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.30e-06 | 190 | 169 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-06 | 191 | 169 | 7 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.59e-06 | 191 | 169 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-06 | 191 | 169 | 7 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-06 | 191 | 169 | 7 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.89e-06 | 192 | 169 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-06 | 192 | 169 | 7 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 8.89e-06 | 192 | 169 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.89e-06 | 192 | 169 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-06 | 192 | 169 | 7 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | eb3c46b6fb06dc8708dc3032189b47ed93ee2357 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.19e-06 | 193 | 169 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 9.19e-06 | 193 | 169 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 9.19e-06 | 193 | 169 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | b45cd02081f97904eaea2d013e1fa980505d060b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.51e-06 | 194 | 169 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.51e-06 | 194 | 169 | 7 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 9.51e-06 | 194 | 169 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-06 | 194 | 169 | 7 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-06 | 194 | 169 | 7 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.51e-06 | 194 | 169 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.51e-06 | 194 | 169 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.51e-06 | 194 | 169 | 7 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-06 | 194 | 169 | 7 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.83e-06 | 195 | 169 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.83e-06 | 195 | 169 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.83e-06 | 195 | 169 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 9.83e-06 | 195 | 169 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.83e-06 | 195 | 169 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 195 | 169 | 7 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| Disease | Malignant neoplasm of breast | SFRP1 ANK1 DYNC2H1 SPTLC1 MED14 BIRC2 SORBS1 DAP3 AKAP9 BRCA2 SNX32 MKI67 ANKRD30A ZFYVE26 MMP2 HERC2 ATP2A3 NIPBL VPS13B | 8.22e-06 | 1074 | 163 | 19 | C0006142 |
| Disease | liver fibrosis measurement | 8.46e-06 | 86 | 163 | 6 | EFO_0010576 | |
| Disease | cancer (implicated_via_orthology) | 1.29e-04 | 268 | 163 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.46e-04 | 157 | 163 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | Malformation of cortical development | 4.48e-04 | 6 | 163 | 2 | cv:C1955869 | |
| Disease | Lissencephaly | 4.48e-04 | 6 | 163 | 2 | cv:C0266463 | |
| Disease | hemoglobin A1 measurement | DLG5 ANK1 NSF SRGAP2 HNRNPUL1 HNRNPAB CNTN5 RCL1 CHFR MAP2K3 | 6.61e-04 | 520 | 163 | 10 | EFO_0007629 |
| Disease | cleft palate (implicated_via_orthology) | 8.31e-04 | 8 | 163 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | colorectal health | 9.08e-04 | 201 | 163 | 6 | EFO_0008460 | |
| Disease | sleep duration | 9.50e-04 | 362 | 163 | 8 | EFO_0005271 | |
| Disease | right ventricular systolic volume measurement | 9.51e-04 | 35 | 163 | 3 | EFO_0021815 | |
| Disease | tropical spastic paraparesis (is_marker_for) | 1.06e-03 | 9 | 163 | 2 | DOID:321 (is_marker_for) | |
| Disease | Glioma | 1.06e-03 | 9 | 163 | 2 | cv:C0017638 | |
| Disease | lifestyle measurement, systolic blood pressure | 1.06e-03 | 9 | 163 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | carotid plaque build | 1.23e-03 | 84 | 163 | 4 | EFO_0006501 | |
| Disease | Drug toxicity | 1.23e-03 | 84 | 163 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 1.23e-03 | 84 | 163 | 4 | C0041755 | |
| Disease | Schizophrenia | IPO5 RELN ACSM1 MC5R CP ADORA1 NPRL2 UFD1 ERVK-8 BRD1 FXYD1 GNPAT RASD2 | 1.29e-03 | 883 | 163 | 13 | C0036341 |
| Disease | abdominal aortic aneurysm (is_marker_for) | 1.33e-03 | 10 | 163 | 2 | DOID:7693 (is_marker_for) | |
| Disease | Carotid Circulation Transient Ischemic Attack | 1.33e-03 | 10 | 163 | 2 | C0751019 | |
| Disease | Transient Ischemic Attack | 1.33e-03 | 10 | 163 | 2 | C0007787 | |
| Disease | Crescendo Transient Ischemic Attacks | 1.33e-03 | 10 | 163 | 2 | C0751021 | |
| Disease | Transient Ischemic Attack, Vertebrobasilar Circulation | 1.33e-03 | 10 | 163 | 2 | C0751020 | |
| Disease | Brain Stem Ischemia, Transient | 1.33e-03 | 10 | 163 | 2 | C0751022 | |
| Disease | Posterior Circulation Transient Ischemic Attack | 1.33e-03 | 10 | 163 | 2 | C0472381 | |
| Disease | Transient Ischemic Attack, Anterior Circulation | 1.33e-03 | 10 | 163 | 2 | C1527335 | |
| Disease | Transient Cerebral Ischemia | 1.33e-03 | 10 | 163 | 2 | C0917805 | |
| Disease | resting heart rate | 1.46e-03 | 149 | 163 | 5 | EFO_0004351 | |
| Disease | thyrotoxic periodic paralysis | 1.61e-03 | 11 | 163 | 2 | MONDO_0019201 | |
| Disease | autistic disorder (is_implicated_in) | 1.62e-03 | 42 | 163 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | SFRP1 ACACA IDH1 ADORA1 CABYR AKAP9 TOMM40L FCN2 MKI67 MMP2 AGTPBP1 | 1.88e-03 | 702 | 163 | 11 | C0009402 |
| Disease | sunburn | 2.01e-03 | 96 | 163 | 4 | EFO_0003958 | |
| Disease | Liver carcinoma | 2.11e-03 | 507 | 163 | 9 | C2239176 | |
| Disease | Short Rib-Polydactyly Syndrome | 2.27e-03 | 13 | 163 | 2 | C0036996 | |
| Disease | male infertility (implicated_via_orthology) | 2.27e-03 | 13 | 163 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Alzheimer's disease biomarker measurement | 2.39e-03 | 48 | 163 | 3 | EFO_0006514 | |
| Disease | brain ischemia (biomarker_via_orthology) | 2.51e-03 | 102 | 163 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | alcohol use disorder (biomarker_via_orthology) | 2.64e-03 | 14 | 163 | 2 | DOID:1574 (biomarker_via_orthology) | |
| Disease | Saldino-Noonan Syndrome | 2.64e-03 | 14 | 163 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 2.64e-03 | 14 | 163 | 2 | C0024507 | |
| Disease | generalised epilepsy | 3.00e-03 | 52 | 163 | 3 | EFO_0005917 | |
| Disease | Influenza | 3.00e-03 | 52 | 163 | 3 | C0021400 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 3.00e-03 | 52 | 163 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | unipolar depression, cognitive function measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | Breast Carcinoma | 3.14e-03 | 538 | 163 | 9 | C0678222 | |
| Disease | waist-hip ratio | EFL1 MYH11 DYNC2H1 LAMB1 SRGAP2 NUP205 TDRD7 ADORA1 DGLUCY CELF1 CNTN5 GLS IL17RD MAP2K3 GNL3 | 3.38e-03 | 1226 | 163 | 15 | EFO_0004343 |
| Disease | phosphatidylcholine 38:6 measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0010388 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.52e-03 | 447 | 163 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 3.91e-03 | 17 | 163 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | squamous cell carcinoma (is_marker_for) | 4.88e-03 | 19 | 163 | 2 | DOID:1749 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.39e-03 | 64 | 163 | 3 | DOID:4947 (is_marker_for) | |
| Disease | exercise test | 5.40e-03 | 20 | 163 | 2 | EFO_0004328 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSAAPGKVICEMKVE | 31 | Q9NPJ3 | |
| PKTCSQKEVMFLGEL | 311 | Q16537 | |
| EKRKGDCVPAVSQSM | 171 | O95696 | |
| TEVQESKKACMFEPL | 2756 | Q99996 | |
| VDAFKECFKMPQSLG | 241 | Q8WYN0 | |
| LEKGTSNMIACPTKE | 386 | Q9BXX2 | |
| SMGEPVIKCEFEKVI | 161 | P30542 | |
| KCVMDSDGSIPALKF | 356 | Q9H2U9 | |
| GCSSPMVVKFADTQK | 176 | Q92879 | |
| QMVCLTKKLPAVEGT | 526 | Q9UNA0 | |
| EASQACMTKKGFTPL | 526 | P16157 | |
| KAAFMKCGSEDTAPV | 396 | Q7Z2Z2 | |
| EKGLAAKCFDMPVSL | 51 | Q2KHT4 | |
| PFITKDMVCAGDAKG | 191 | P49863 | |
| MGQTKCFISIELKPE | 5441 | Q8WXG9 | |
| TCGMKVSIPTKALEL | 611 | Q9BXX3 | |
| AVSMSDKKGICVADP | 806 | P01024 | |
| KTCVFEKENDPSVMR | 741 | Q13085 | |
| NDPSFEDMKKVVCVD | 431 | P37023 | |
| SAAKDCVPECKVSMV | 1001 | Q9UKA4 | |
| TVPKGCFMANVADKS | 251 | O94923 | |
| EDVMVAAPLVCSGKV | 216 | O75952 | |
| KKKPEDAFCVVGITM | 161 | Q86W34 | |
| VKCVKMLLESGADPT | 261 | Q9H9E1 | |
| TAPGFTAEMKKDCSL | 546 | Q9UPW5 | |
| AKQLKDSVTCSPGMV | 371 | Q96KC8 | |
| KMFVKGAPESVIERC | 511 | Q93084 | |
| VPVGCDKEVGSMKAD | 686 | Q8WXS8 | |
| GFDMSCIKDVAIKEP | 221 | Q99873 | |
| TAAKGTTVKMECFAL | 311 | O94779 | |
| DKKYGFCPETAMSTV | 326 | P08253 | |
| QIMFKIETKPCGEEL | 336 | Q9Y2P8 | |
| IKTTIVCPFFIKTGM | 216 | Q8N3Y7 | |
| KEKKCFPEGTDMVGI | 396 | O94925 | |
| MLGTCPTKEDKEAFA | 416 | Q14573 | |
| IKELCQSVMPAGVDK | 1851 | Q92621 | |
| VKKFVSCDVMLEPGE | 876 | O75808 | |
| TKDIFTGLIGPMKIC | 546 | P00450 | |
| EAMVLKKEFLPSCSS | 256 | Q9C0D6 | |
| VGTVSKPCFTAYEMK | 286 | Q460N3 | |
| KPCFTAYEMKIGAIT | 291 | Q460N3 | |
| KFDSGLVLNDVMCKP | 581 | Q8NFM7 | |
| FMISPETVTGTGKKC | 621 | P27816 | |
| MGCVFCKKLEPVATA | 1 | P09769 | |
| PSIFGGTDMKKAIAC | 341 | P33992 | |
| PFCAVKMKEALSTER | 26 | Q05655 | |
| MKEEDSSFKLCVPGI | 1 | Q5YKI7 | |
| GSDGCKVPMKIDSLT | 4181 | O95714 | |
| MEIEESRQKCGATPK | 1126 | Q9P2D0 | |
| KMVCSDSPFAGALRK | 91 | Q15751 | |
| VTQHGKPMFTKVCTE | 126 | O43679 | |
| EGVVTKCKPVMIITE | 686 | P54764 | |
| VLGTAEFTEMCPKGK | 1391 | Q14766 | |
| LADMLSFCGKKVVTA | 356 | Q9BUK6 | |
| TGEKQPLKVFMDVCL | 141 | Q5VWM3 | |
| VVPFAKAVCEMSKQS | 501 | Q8IVU3 | |
| KAMKCLSEVVAVDPS | 1791 | Q6KC79 | |
| VVKEMLVNEAPGKFC | 1751 | Q8TDM6 | |
| DLVPCGVFMKIVTTD | 211 | P42785 | |
| SCFAVMGVPEKIKTD | 696 | P63132 | |
| CVGLLTMAKAESPKE | 11 | O00168 | |
| MVPKTIAGKIFGSIC | 376 | Q9NZV8 | |
| GISTGPMKKVDDIIC | 176 | P07942 | |
| KICSPDKMIGFSETA | 566 | P46459 | |
| KRIGEFKESIPKMCS | 831 | Q96CW5 | |
| SQPCIKMEGDKSLTF | 46 | P59047 | |
| EAVAAGKTTKMPCES | 1361 | P46013 | |
| MPTVCTTIKVSKDGQ | 51 | Q9BSC4 | |
| PVIKFCTSAADMKIR | 91 | Q8NFH4 | |
| NCISAVGKIMKFKPD | 971 | O00410 | |
| SIVCMAAKEVSAPKA | 66 | Q9Y6Z4 | |
| SCFAVMGVPEKIKTD | 696 | P63135 | |
| SCFAVMGVPEKIKTD | 696 | Q9BXR3 | |
| MVFLKDGERKLCTPS | 451 | P78509 | |
| EPGVIMFKTDALKCR | 1236 | O60244 | |
| ESLVVPFAKVVCKMS | 506 | Q9UII4 | |
| EMKGSAITGPVAKEC | 111 | P62829 | |
| SCFAVMGVPEKIKTD | 696 | Q9QC07 | |
| VEFLKKMESRGPLSC | 131 | O14976 | |
| MCEQEFPSILAKKVS | 3656 | Q8NCM8 | |
| AAGKPDKMEETLTCI | 291 | Q96EP1 | |
| MTSVLVCPDGKTVEA | 291 | O75874 | |
| AAKIEKDRTVMPCGT | 401 | Q9Y426 | |
| EPATTKLEEMLGCKT | 656 | O15228 | |
| MSGLEKVSKISPCDV | 1936 | P51587 | |
| TCPEVKMVGLEGSDK | 31 | Q15485 | |
| GKEECASVSSVPMVF | 36 | Q86WZ0 | |
| VKNKSSPCEDMGIAV | 26 | P33032 | |
| MKEFTPEYKGVVSVC | 66 | Q92551 | |
| SNVEPMEKEFGLCKT | 101 | Q9BVP2 | |
| ICSKFGALPFVAEKM | 261 | Q8IYX8 | |
| GKTIDCKDAIFIMTS | 481 | Q9H078 | |
| TSKCPGRFFALMEIK | 446 | O75881 | |
| MKEIIFDFLCVGKPA | 471 | Q5TBA9 | |
| KKETAIFGSCMPALS | 1671 | Q8NDH2 | |
| FSDMKTLVNPKCGII | 1696 | Q8NDH2 | |
| SIPGCTVMTDLKDAK | 246 | Q7Z3D6 | |
| EGRPMFVSPCVDKSK | 771 | Q15020 | |
| KVKPEELESFCEGGM | 606 | O95104 | |
| MPIECAEVFSKTVAG | 1306 | Q92736 | |
| VITFCFTPKLMAVGK | 341 | Q6ZTR5 | |
| TKDGKLPFCAMGVSS | 231 | P36551 | |
| AAAGSKRPTCVIMVK | 116 | Q9NX24 | |
| PLSAGMSCEVLVTFK | 571 | Q9C0B2 | |
| PPKFSKVEDMAELTC | 81 | P35580 | |
| DMVSKEKIISFVACG | 81 | Q8NH01 | |
| GTVGPKSKAECEILM | 411 | Q9BUJ2 | |
| SPVKICDFDLGSGMK | 226 | Q9BUB5 | |
| VDSVAKTMDAGCKPY | 216 | P46734 | |
| DKKTISFPACMGQLF | 86 | P0C604 | |
| VKTFSEACLMVRKPA | 91 | P51398 | |
| MSKIADFLKAGCEVT | 56 | P54577 | |
| KFGEVVDCTIKMDPN | 91 | Q99729 | |
| TCITFQPDLSKFKME | 236 | Q02880 | |
| KFTKLCEFPMLETGL | 301 | Q8IVB4 | |
| IGCKKPVSASGKEMD | 151 | Q9UPR3 | |
| EKLPMTFQSCVITKE | 346 | Q9UPZ6 | |
| KEGIQTCMFPKETDI | 1076 | A2VDJ0 | |
| VVVATAISGGCKMPK | 291 | Q7LBE3 | |
| CFEIAKMEGFPKDVV | 896 | O60502 | |
| TGEKQPLKVFMDVCL | 141 | Q5SWL8 | |
| DKMAALFTKVGKTCP | 66 | O43147 | |
| AKTTRPCGMAEFKEK | 6 | Q53H47 | |
| VFVGPRKLCVKEMNS | 716 | Q13621 | |
| SSETTMVKKKVVFCP | 201 | Q9UBE0 | |
| KKPGLEEAVESACAM | 871 | Q9NSE4 | |
| KGCPTVMAGDFKEKV | 331 | Q8NHU6 | |
| TVTAMEKKLIGCPVC | 56 | Q8WTW4 | |
| PVKENEMKASSCFLI | 291 | Q7Z745 | |
| KCDKFPEGDVCIAMT | 156 | Q8N474 | |
| CSVLKGSEFMFEKAP | 261 | Q5JTH9 | |
| MEENPGIFAVLKEKC | 356 | O15269 | |
| CKVCMDKEVSVVFIP | 571 | Q13490 | |
| TMKIPDDPKASFENC | 96 | O95561 | |
| TCVKSKTLDPMVIFF | 211 | Q08AH1 | |
| VPFTCTIITKKEVEM | 411 | Q8NA66 | |
| PPKFSKVEDMAELTC | 81 | P35749 | |
| YKSVAENMGCEKPVI | 371 | Q70EK8 | |
| VVKGNKDVFVCMPTG | 41 | O94762 | |
| KDVFVCMPTGAGKSL | 46 | O94762 | |
| KDIMKIGCSLSEVCP | 56 | Q9BXU1 | |
| GVSPCKVTAEKLMDL | 346 | Q9UBS8 | |
| GTLGKFTVPMLKEAC | 571 | P12956 | |
| ICPFEEKTKIGTMVE | 16 | Q6V9R5 | |
| FPTIGMLSCGEKVKV | 421 | Q8NCJ5 | |
| TGEKPYECEKVSIQM | 106 | Q3ZCT1 | |
| AVCMPCKDAKSEGVV | 1296 | Q8IZQ1 | |
| LYKDVASGPCKIVMS | 341 | Q9UQR0 | |
| GADPSKCIVKITGEM | 576 | Q9BQI5 | |
| KCIVKITGEMVLSFP | 581 | Q9BQI5 | |
| PVASVVMDKDKGVFA | 81 | Q9H6E5 | |
| GDIACAFRPVKSVKM | 1016 | O75044 | |
| PTDMDLTKICTGKGA | 56 | Q9BX66 | |
| SCFAVMGVPEKIKTD | 696 | P10266 | |
| SCFAVMGVPEKIKTD | 696 | P63133 | |
| SCFAVMGVPEKIKTD | 696 | Q9UQG0 | |
| KTKEAAELPMVICGN | 126 | Q96D21 | |
| KVSGPMQDSFKEECE | 466 | Q5T7W7 | |
| KAFCGFEDPRTKTKM | 4491 | Q15149 | |
| QTEKGCEAPKEVSTM | 411 | Q8IUG5 | |
| VMETKPDKAVSIIEC | 171 | Q92890 | |
| SGLCKFPEVEGKMTT | 11 | Q9UK13 | |
| VKTDDSVVPCFMKRQ | 286 | P33981 | |
| CLFEVVNKGMDPVDK | 246 | O43592 | |
| GTMGSIKICAKAPVD | 871 | Q7Z7G8 | |
| LCKDVFPAQMEGVKL | 36 | Q969M1 | |
| KPEECAMFSAPVDEK | 151 | Q8N831 | |
| VFFKGPGKVVMVAIC | 231 | Q6PML9 | |
| IDTFKVPKEMFTVGC | 486 | Q9H1V8 | |
| ICGDVLANEAMKPSK | 761 | Q6R2W3 | |
| GESKCPLMVKVLDAV | 26 | P02766 | |
| KKVSCMFIPDGRVSV | 166 | Q9H3M7 | |
| METYAEVGKEGKPSC | 1 | Q86XE0 | |
| CSTKKMVVEGCRENP | 1846 | Q68DK2 | |
| AFPVKEICAEKGDDM | 1076 | Q9BVV6 | |
| SGMDVTLLDPTCKAK | 476 | Q03167 | |
| KMCIDPSLSVALGDK | 321 | Q9P2D8 | |
| ILKSAKDGIMDSCAP | 236 | P58304 | |
| LKLPCEMDFSGKDVS | 246 | P23378 | |
| VSKDSEGKLMCKPIF | 301 | P41091 | |
| SSPVDMLGVVLAKKC | 2601 | P20929 |